The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Kardos P, Hagedorn-Peinz I
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2017-12-01
Serija:	International Journal of COPD
Teme:	COPD dual-bronchodilators FEV1 indacaterol/glycopyrronium treatment preference treatment satisfaction
Online dostop:	https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD
Oznake:	Označite Brez oznak, prvi označite!